Free shipping on all orders over $ 500

IMM-H007

Cat. No. M11462
IMM-H007 Structure
Size Price Availability Quantity
5mg USD 230  USD230 In stock
10mg USD 310  USD310 In stock
25mg USD 630  USD630 In stock
50mg USD 940  USD940 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Imm-h007 is an adenosine derivative that is an activator of the AMP-Activated Protein Kinase (AMPK). Imm-h007 is a potential drug for the treatment of cardiac insufficiency. Imm-h007 negatively regulates endothelial inflammation by inactivating NF-κB and JNK/AP1 signaling. Imm-h007 can inhibit the degradation of ABCA1 (ATP binding cassette subfamily a member 1) and promote its cell surface localization in macrophages, thus promoting cholesterol efflux.

Chemical Information
Molecular Weight 485.45
Formula C22H23N5O8
CAS Number 1221412-23-2
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Shuai-Xing Wang, et al. Acta Pharmacol Sin. IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway

[2] Z-L Zhang, et al. Eur Rev Med Pharmacol Sci. Preclinical pharmacokinetic study of a novel lipid-lowering agent, IMM-H007

[3] Jinjin Yu, et al. Toxicol Appl Pharmacol. IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling

[4] Weipeng Ge, et al. Eur J Pharmacol. IMM-H007 improves heart function via reducing cardiac fibrosis

[5] Min-Jie Wang, et al. Eur J Pharmacol. The cordycepin derivative IMM-H007 improves endothelial dysfunction by suppressing vascular inflammation and promoting AMPK-dependent eNOS activation in high-fat diet-fed ApoE knockout mice

Related AMPK Products
SAMS

SAMS peptide is a specific substrate for the AMP-activated protein kinase (AMPK).

Marein

Marein has the neuroprotective effect due to a reduction of damage to mitochondria function and activation of the AMPK signal pathway.

Malvidin-3-O-arabinoside chloride

Malvidin-3-O-arabinoside chloride ameliorates ethyl carbamate-induced oxidative damage by stimulating AMPK-mediated autophagy.

AMPK activator 12

AMPK activator 12 is a potent AMPK activator and GDF15 inducer.

Kazinol U

Kazinol U inhibits melanogenesis through the inhibition of tyrosinase-related proteins via AMPK activation.

  Catalog
Abmole Inhibitor Catalog




Keywords: IMM-H007 supplier, AMPK, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.